SCHEMBL8772134

SCHEMBL8772134

CC(C)(C)[Si](C)(C)OCc1cccc(/C=C/C=C/CO)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
BACE1 P56817 1/20 0.35
IDO1 P14902 3/20 0.34
CCNB2 O95067 3/20 0.33
CDK1 P06493 3/20 0.33
CDK4 P11802 3/20 0.33
CCNB1 P14635 3/20 0.33
CCND1 P24385 3/20 0.33
CCNB3 Q8WWL7 3/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
PKM P14618 1/20 0.32
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31
MAOA P21397 1/20 0.30
MAOB P27338 1/20 0.30
USP14 P54578 1/20 0.30
AGXT P21549 1/20 0.30
PLAU P00749 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9626381 0.86 BACE1 (0.35) CYP4F2CYP4A11BACE1IDO1CCNB2
SCHEMBL8772163 0.84 CCNB2 (0.44) CYP4F2CYP4A11BACE1IDO1CCNB2
SCHEMBL20298754 0.81 LCK (0.44) BACE1IDO1CCNB2CDK1CDK4
SCHEMBL8772123 0.79 MAOB (0.43) BACE1KDM4EALDH1A1MAOAMAOB
SCHEMBL8891484 0.79 MAOB (0.43) BACE1KDM4EALDH1A1MAOAMAOB
Alcohol SCHEMBL9337072 0.78 MAOA (0.43) CYP4F2CYP4A11BACE1KDM4EALDH1A1
SCHEMBL4332449 0.77 MAOA (0.47) BACE1IDO1ALDH1A1MAOAMAOB
SCHEMBL5871100 0.77 TP53 (0.40) BACE1IDO1ALDH1A1MAOAMAOB
SCHEMBL8344755 0.77 BACE1 (0.34) BACE1IDO1CCNB2CDK1CDK4
SCHEMBL14566164 0.77 ENPP2 (0.40) BACE1IDO1KDM4EALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0801061-A2 Leucotrien-B4 derivatives, process for their preparation and their use as medicaments SCHERING AKTIENGESELLSCHAFT (DE) 1997-10-15 EP disclosed
US-5614634-A Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1997-03-25 US disclosed
US-5440044-A Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1995-08-08 US disclosed
EP-0477311-A1 NEW LEUCOTRIENE B 4? DERIVATIVES, METHODS OF PREPARING THEM AND THEIR USE AS DRUGS SCHERING AKTIENGESELLSCHAFT (DE) 1992-04-01 EP disclosed
WO-1991014676-A1 NEW LEUCOTRIENE B4 DERIVATIVES, METHODS OF PREPARING THEM AND THEIR USE AS DRUGS SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) 1991-10-03 WO disclosed